149 related articles for article (PubMed ID: 23057495)
1. Phase II study of preoperative chemoradiation with S-1 plus oxaliplatin in patients with locally advanced rectal cancer.
Lee EM; Hong YS; Kim KP; Lee JL; Kim SY; Park YS; Choi DH; Kim JH; Lim SB; Yu CS; Kim JC; Lee JH; Kim AY; Kim TW
Cancer Sci; 2013 Jan; 104(1):111-5. PubMed ID: 23057495
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study.
Yang B; Shan J; Feng Y; Dai N; Li M; Chen C; He S; Wang G; Xiao H; Li C; Wang D
Radiat Oncol; 2020 May; 15(1):94. PubMed ID: 32375814
[TBL] [Abstract][Full Text] [Related]
3. Phase II Study of Preoperative Chemoradiotherapy With S-1 Plus Oxaliplatin for Locally Advanced Rectal Cancer (PerSeUS-RC01).
Matsuhashi N; Takahashi T; Tanaka C; Yawata K; Yamada M; Iwata Y; Kiyama S; Mizutani C; Tajima JY; Ishihara T; Yoshida K
Anticancer Res; 2021 Dec; 41(12):6247-6257. PubMed ID: 34848480
[TBL] [Abstract][Full Text] [Related]
4. Preoperative chemoradiotherapy with oxaliplatin and tegafur-uracil in locally advanced rectal cancer: pathologic complete response rate and preliminary results of overall and disease-free survival in a single institute in Taiwan.
Chao JY; Wang HM; Chiang FF; Lin JC; Chang CF; Lin JF; Yeh HL
J Chin Med Assoc; 2014 Mar; 77(3):128-32. PubMed ID: 24398439
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of preoperative concurrent chemoradiotherapy with S-1 for locally advanced, resectable rectal adenocarcinoma.
Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamijo A; Murayama C; Akiba T; Nakayama Y
Oncology; 2011; 81(5-6):306-11. PubMed ID: 22156392
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of a multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (JACCRO CC-04: SHOGUN Trial).
Kondo K; Matsusaka S; Ishihara S; Horie H; Uehara K; Oguchi M; Murafushi K; Ueno M; Mizunuma N; Shimbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Fujii M; Nakajima T
Radiother Oncol; 2019 May; 134():199-203. PubMed ID: 31005216
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer.
Sato H; Shimada M; Kurita N; Iwata T; Yoshikawa K; Higashigima J; Chikakio M; Kashihara H; Takasu C; Matsumoto N; Eto S
Int J Clin Oncol; 2015 Jun; 20(3):543-8. PubMed ID: 25080061
[TBL] [Abstract][Full Text] [Related]
8. A phase I dose escalation study of oxaliplatin plus oral S-1 and pelvic radiation in patients with locally advanced rectal cancer (SHOGUN trial).
Ishihara S; Matsusaka S; Kondo K; Horie H; Uehara K; Oguchi M; Murofushi K; Ueno M; Mizunuma N; Shinbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Nakajima T; Watanabe T
Radiat Oncol; 2015 Jan; 10():24. PubMed ID: 25612635
[TBL] [Abstract][Full Text] [Related]
9. A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer.
Kim HS; Park MJ; Uhm JE; Lee Y; Lee HY; Kang EM; Lee J; Park SH; Park JO; Lim HY; Kang WK; Park YS
Int J Colorectal Dis; 2009 Nov; 24(11):1311-6. PubMed ID: 19609538
[TBL] [Abstract][Full Text] [Related]
10. A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis.
Ohue M; Hamaguchi T; Ito Y; Sakai D; Noura S; Kinugasa Y; Fujita S; Shimada Y; Saito N; Moriya Y
Int J Clin Oncol; 2015 Apr; 20(2):338-44. PubMed ID: 24839048
[TBL] [Abstract][Full Text] [Related]
11. A multicenter phase II study of preoperative chemoradiotherapy with S-1 plus oxaliplatin for locally advanced rectal cancer (SHOGUN trial).
Matsusaka S; Ishihara S; Kondo K; Horie H; Uehara K; Oguchi M; Murofushi K; Ueno M; Mizunuma N; Shimbo T; Kato D; Okuda J; Hashiguchi Y; Nakazawa M; Sunami E; Kawai K; Yamashita H; Okada T; Ishikawa Y; Nakajima T; Watanabe T
Radiother Oncol; 2015 Aug; 116(2):209-13. PubMed ID: 26337743
[TBL] [Abstract][Full Text] [Related]
12. [Response in a case of advanced rectal cancer treated by chemoradiation with S-1/oxaliplatin].
Saito M; Ishi Y; Kikuchi D; Yamada M; Takenoshita S
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1217-9. PubMed ID: 21772116
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Eisterer W; Piringer G; DE Vries A; Öfner D; Greil R; Tschmelitsch J; Samonigg H; Sölkner L; Gnant M; Thaler J;
Anticancer Res; 2017 May; 37(5):2683-2691. PubMed ID: 28476845
[TBL] [Abstract][Full Text] [Related]
14. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer.
Qiu M; Peng XC; Bi F; Wang X; Li Q; Xu F; Li ZP; Shen YL; Liu JY; Zhao YQ; Cao D; Gou HF; Yang Y; Chen Y; Yi C
Med Oncol; 2015 Jul; 32(7):191. PubMed ID: 26025485
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of preoperative chemoradiation with s-1 and oxaliplatin in patients with locally advanced resectable rectal cancer.
Hong YS; Lee JL; Park JH; Kim JH; Yoon SN; Lim SB; Yu CS; Kim MJ; Jang SJ; Lee JS; Kim JC; Kim TW
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):684-9. PubMed ID: 20452140
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results.
Park SR; Kong SY; Rhee J; Park YI; Ryu KW; Lee JH; Kim YW; Choi IJ; Kim CG; Lee JY; Cho SJ; Kim NK
Ann Oncol; 2011 Apr; 22(4):890-896. PubMed ID: 20860988
[TBL] [Abstract][Full Text] [Related]
17. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.
Calvo FA; Serrano FJ; Diaz-González JA; Gomez-Espi M; Lozano E; Garcia R; de la Mata D; Arranz JA; García-Alfonso P; Pérez-Manga G; Alvarez E
Ann Oncol; 2006 Jul; 17(7):1103-10. PubMed ID: 16670204
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative chemoradiotherapy with S-1 for advanced low rectal cancer].
Kitani K; Okajima K; Sato K; Isono S; Kimura H; Ikeda M; Inoue K; Iwama M; Tsujie M; Nakayama T; Fujiwara Y; Murata M; Yukawa M; Ota Y; Inoue M
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2122-4. PubMed ID: 22202303
[TBL] [Abstract][Full Text] [Related]
19. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
